ChemicalBook > Product Catalog >API >Drugs Influencing Immune Function >Immunosuppressive drugs >Nerelimomab [usan:inn]

Nerelimomab [usan:inn]

Request For Quotation
Nerelimomab [usan:inn] Suppliers list
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  Gold
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Email: orders@jknbiochem.com
Nerelimomab [usan:inn] Basic information
Product Name:Nerelimomab [usan:inn]
Synonyms:Nerelimomab;Nerelimomab [usan:inn];Research Grade Nerelimomab
CAS:162774-06-3
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Nerelimomab [usan:inn] Structure
Nerelimomab [usan:inn] Chemical Properties
Safety Information
MSDS Information
Nerelimomab [usan:inn] Usage And Synthesis
UsesMonoclonal antibody.
in vivo

Nerelimomab (7.5 mg/kg, i.v. infusion) protected animals from death in a baboon model of recurrent bacteremia[1].

Animal Model:Baboon model of recurrent bacteremia (Challenged with E.coli)[1]
Dosage:7.5 mg/kg
Administration:i.v. infusion
Result:Improved organ function and attenuated cytokine and plasminogen activator inhibitor release.
Nerelimomab [usan:inn] Preparation Products And Raw materials
Tag:Nerelimomab [usan:inn](162774-06-3) Related Product Information
Letolizumab Nofazinlimab Plonmarlimab Ongericimab dinutuximab Solitomab Zalifrelimab Duvortuxizumab Alsevalimab Ormutivimab